New effort ranks drugmakers by impact
Pharmaceutical companies have one very obvious reason to avoid developing drugs and vaccines for infectious diseases like malaria and tuberculosis: There’s basically no money in it.
That’s because most people with those conditions are poor and have little means to pay. So what kind of incentive do you need to get drugmakers to take on global health epidemics? The answer may be a new index that ranks companies by who has the most effective drugs.
Click the media player above to hear more.
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
